United Kingdom· GB-APID-39329111000001107
Bevespi Aerosphere 7.2micrograms/dose / 5micrograms/dose pressurised inhaler
A medicinal product containing glycopyrronium bromide + formoterol, registered in United Kingdom by AstraZeneca UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Glycopyrronium bromide + Formoterol
- Manufacturer
- AstraZeneca UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05000456055482
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glycopyrronium bromide + formoterol in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBEVESPI AEROSPHEREAstraZeneca AB, Södertälje
- FinlandBevespi AerosphereAstraZeneca AB
- NorwayBevespi AerosphereAstraZeneca AB (2)
- SwedenBevespi Aerosphere 7,2 mikrogram/5 mikrogram Inhalationsspray, suspensionAstraZeneca AB
- United StatesBEVESPI AEROSPHEREAstraZeneca Pharmaceuticals LP
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bevespi Aerosphere
- Liechtenstein · Bevespi Aerosphere
- Norway · Bevespi Aerosphere
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5e67e719-d7ac-4f0c-870b-6aa809869cf2 GET /v1/drugs/5e67e719-d7ac-4f0c-870b-6aa809869cf2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39329111000001107",
"desc": "Bevespi Aerosphere 7.2micrograms/dose / 5micrograms/dose pressurised inhaler (AstraZeneca UK Ltd)",
"form": "Pressurised inhalation",
"vpid": "39343611000001104",
"source": "dmd",
"vtm_id": "39335411000001102",
"strength": "7.2 microgram",
"substance": "Glycopyrronium bromide + Formoterol",
"ingredient": "Glycopyrronium bromide",
"supplier_code": "3583301000001102"
}See everything about glycopyrronium bromide + formoterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.